Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Devine

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|October 25, 2008
Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphomaMehdi Hamadani, Farrukh T Awan, Patrick Elder, et al.
Blood Advances|October 5, 2024
Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomesStephen R Spellman, Rodney Sparapani, Martin Maiers, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 19, 2012
Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myelomaJarrod T Bruce, Jerry M Tran, Gary Phillips, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research studyNelli Bejanyan, Daniel J Weisdorf, Brent R Logan, et al.
Journal of the American Academy of Dermatology|July 5, 2014
Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entityBenjamin H Kaffenberger, Rena C Zuo, Alejandro Gru, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2018
MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector FunctionNina C Zitzer, Katiri Snyder, Xiamoei Meng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 20, 2014
Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II studyThomas Bechtel, Ali McBride, Brooke Crawford, et al.
Blood|May 14, 2005
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF aloneNeal Flomenberg, Steven M Devine, John F Dipersio, et al.
Blood Advances|December 11, 2019
Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantationYi-Bin Chen, Nirav N Shah, Anne S Renteria, et al.
Best Practice & Research. Clinical Haematology|December 3, 2014
Improved accuracy of acute graft-versus-host disease staging among multiple centersJohn E Levine, William J Hogan, Andrew C Harris, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|October 25, 2008
Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphomaMehdi Hamadani, Farrukh T Awan, Patrick Elder, et al.
Blood Advances|October 5, 2024
Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomesStephen R Spellman, Rodney Sparapani, Martin Maiers, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 19, 2012
Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myelomaJarrod T Bruce, Jerry M Tran, Gary Phillips, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research studyNelli Bejanyan, Daniel J Weisdorf, Brent R Logan, et al.
Journal of the American Academy of Dermatology|July 5, 2014
Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entityBenjamin H Kaffenberger, Rena C Zuo, Alejandro Gru, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2018
MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector FunctionNina C Zitzer, Katiri Snyder, Xiamoei Meng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 20, 2014
Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II studyThomas Bechtel, Ali McBride, Brooke Crawford, et al.
Blood|May 14, 2005
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF aloneNeal Flomenberg, Steven M Devine, John F Dipersio, et al.
Blood Advances|December 11, 2019
Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantationYi-Bin Chen, Nirav N Shah, Anne S Renteria, et al.
Best Practice & Research. Clinical Haematology|December 3, 2014
Improved accuracy of acute graft-versus-host disease staging among multiple centersJohn E Levine, William J Hogan, Andrew C Harris, et al.
Pageof 18